NCT00289367 - Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery | Biotech Hunter

Enrollment

280

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

May 31, 2008

Conditions

Atrial Fibrillation

Interventions

DRUG

Triiodothyronine

0.8 mcg/kg bolus loading dose followed by a six hour infusion of 0.8 mcg/kg/6hr.

DRUG

triiodothyronine

IV formulation - Triostat, 0.8 mcg/kg bolus loading dose followed by a six hour infusion of 0.8 mcg/kg/6hr.

Trial Locations (1)

North Shore University Hospital, Manhasset